Watchlist Price Alert

Acurx Pharmaceuticals Inc... (ACXP)

NASDAQ: ACXP · Real-Time Price · USD

0.35

0.00 (0.73%)

At close: Jun 06, 2025, 3:59 PM

0.34

-3.38%

After-hours: Jun 06, 2025, 05:57 PM EDT

Acurx Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.12M	-3.12M	-3.44M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M	-4M	-1.47M	-1.09M	-1.31M	-913K	-1.28M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	443.68K	538.37K	317.56K	1.02M	1.2M	1.23M	833.28K	806.49K	899.38K	696.97K	824.04K	716.68K	949.17K	581.4K	3.4M	2.26M	327.14K	285.77K	306.64K	166.67K	347.77K
Other Working Capital	-397.11K	-53.22K	-125.88K	-31.63K	-14.33K	-310.15K	188.19K	1.06M	-12.3M	-265.32K	537.5K	283.23K	210.73M	-21.23K	-1.39M	1.48M	-316.71K	-152.5K	249.14K	-148.15K	-749.66K
Other Non-Cash Items	n/a	1.12B	314.88K	256.18K	67.8K	393.68K	833.28K	945.43K	899.38K	812.47K	708.2K	-159.15K	-210.88K	310.21K	46.07K	-66.5K	916.76K	-111.98K	375.51K	n/a	781.7K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-346K	-6.98K	-126K	-31.63K	114.83K	-1.32M	188.19K	116.66K	70.65K	952.46K	-171K	72.35K	-155K	366.75K	-1.39M	1.48M	-317K	-40.52K	5.28K	-148K	-750K
Operating Cash Flow	-2.05M	-2.25M	-2.19M	-2.88M	-3.06M	-4.2M	-2.09M	-1.58M	-1.93M	-1.5M	-2.18M	-1.99M	-1.88M	-1.5M	-2.64M	-330K	-547K	-960K	-759K	-734K	-899K
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	66.5K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.99B	200.76M	6.41B	320.21K	210.2K	4.62M	3.54M	73.00	n/a	-3.7M	3.7M	n/a	n/a	14.78B	n/a	n/a	n/a	n/a	n/a	1.12M	n/a
Financial Cash Flow	2.99B	194.55K	6.42B	320.21K	4.51M	4.62M	n/a	3.54M	n/a	-1	3.69M	n/a	n/a	14.78B	n/a	14.8M	n/a	728.54K	2.19M	1.12M	n/a
Net Cash Flow	937.17M	-2.06M	-598K	-2.56M	1.45M	421.86K	-2.09M	1.97M	-1.93M	-1.5M	1.51M	-1.99M	-1.88M	-1.5M	-2.64M	14.47M	-547K	-231K	1.43M	390.41K	-899K
Free Cash Flow	-2.05M	-2.25M	-2.19M	-2.88M	-3.06M	-4.2M	-2.09M	-1.58M	-1.93M	-1.5M	-2.18M	-1.99M	-1.88M	-1.5M	-2.64M	-330K	-547K	-960K	-759K	-734K	-899K